TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Enorama Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
912
|
4,575
|
8,025 |
| Financial expenses |
2,411
|
1,395
|
583 |
| Earnings before taxes |
-29,965
|
-28,086
|
-20,172 |
| EBITDA |
-25,913
|
-25,348
|
-18,585 |
| Total assets |
23,096
|
32,557
|
37,035 |
| Current assets |
8,708
|
7,853
|
16,294 |
| Current liabilities |
6,863
|
8,303
|
8,491 |
| Equity capital |
13,123
|
21,065
|
15,527 |
| - share capital |
4,295
|
976
|
873 |
| Employees (average) |
5
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
56.8%
|
64.7%
|
41.9% |
| Turnover per employee |
182
|
508
|
802 |
| Profit as a percentage of turnover |
-3285.6%
|
-613.9%
|
-251.4% |
| Return on assets (ROA) |
-119.3%
|
-82.0%
|
-52.9% |
| Current ratio |
126.9%
|
94.6%
|
191.9% |
| Return on equity (ROE) |
-228.3%
|
-133.3%
|
-129.9% |
| Change turnover |
-3,687
|
-2,799
|
6,464 |
| Change turnover % |
-80%
|
-38% | |
| Chg. No. of employees |
-4
|
-1
|
3 |
| Chg. No. of employees % |
-44%
|
-10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.